Nothing Special   »   [go: up one dir, main page]

GB9420754D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9420754D0
GB9420754D0 GB9420754A GB9420754A GB9420754D0 GB 9420754 D0 GB9420754 D0 GB 9420754D0 GB 9420754 A GB9420754 A GB 9420754A GB 9420754 A GB9420754 A GB 9420754A GB 9420754 D0 GB9420754 D0 GB 9420754D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9420754A
Other versions
GB2282759A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of GB9420754D0 publication Critical patent/GB9420754D0/en
Publication of GB2282759A publication Critical patent/GB2282759A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catching Or Destruction (AREA)
GB9420754A 1993-10-16 1994-10-14 Use of acyclovir in treatment of post-herpetic neuralgia Withdrawn GB2282759A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321394A GB9321394D0 (en) 1993-10-16 1993-10-16 Pharmaceuticals

Publications (2)

Publication Number Publication Date
GB9420754D0 true GB9420754D0 (en) 1994-11-30
GB2282759A GB2282759A (en) 1995-04-19

Family

ID=10743678

Family Applications (2)

Application Number Title Priority Date Filing Date
GB939321394A Pending GB9321394D0 (en) 1993-10-16 1993-10-16 Pharmaceuticals
GB9420754A Withdrawn GB2282759A (en) 1993-10-16 1994-10-14 Use of acyclovir in treatment of post-herpetic neuralgia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB939321394A Pending GB9321394D0 (en) 1993-10-16 1993-10-16 Pharmaceuticals

Country Status (9)

Country Link
EP (1) EP0723448A1 (en)
JP (1) JPH09503779A (en)
AU (1) AU7860394A (en)
BE (1) BE1007586A3 (en)
CA (1) CA2174240A1 (en)
FR (1) FR2711061B1 (en)
GB (2) GB9321394D0 (en)
WO (1) WO1995011027A1 (en)
ZA (1) ZA948065B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1093366T1 (en) * 1998-07-09 2005-02-28 Warner-Lambert Company Llc Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles

Also Published As

Publication number Publication date
BE1007586A3 (en) 1995-08-16
FR2711061B1 (en) 1995-12-01
GB2282759A (en) 1995-04-19
ZA948065B (en) 1996-04-10
JPH09503779A (en) 1997-04-15
GB9321394D0 (en) 1993-12-08
CA2174240A1 (en) 1995-04-27
EP0723448A1 (en) 1996-07-31
WO1995011027A1 (en) 1995-04-27
AU7860394A (en) 1995-05-08
FR2711061A1 (en) 1995-04-21

Similar Documents

Publication Publication Date Title
AP9300494A0 (en) Pharmaceuticals
GB9305593D0 (en) Pharmaceuticals
GB9301660D0 (en) Pharmaceuticals
GB9312348D0 (en) Pharmaceuticals
GB9321811D0 (en) Pharmaceuticals
GB9321812D0 (en) Pharmaceuticals
GB9320316D0 (en) Pharmaceuticals
AP9400684A0 (en) Pharmaceuticals
GB9303340D0 (en) Pharmaceuticals
GB9321394D0 (en) Pharmaceuticals
GB9326177D0 (en) Pharmaceuticals
GB9311878D0 (en) Pharmaceuticals
GB9311864D0 (en) Pharmaceuticals
GB9309643D0 (en) Pharmaceuticals
GB9310776D0 (en) Pharmaceuticals
GB9321255D0 (en) Pharmaceuticals
GB9320770D0 (en) Pharmaceuticals
GB9320766D0 (en) Pharmaceuticals
GB9320485D0 (en) Pharmaceuticals
GB9309644D0 (en) Pharmaceuticals
GB9310195D0 (en) Pharmaceuticals
GB9309642D0 (en) Pharmaceuticals
GB9307126D0 (en) Pharmaceuticals
GB9313922D0 (en) Pharmaceuticals
GB9315202D0 (en) Pharmaceuticals

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)